REFERENCES
- Braumarr K.M., Nonnast-Daniel B., Boning D., Bocker A., Frei U. Improved Physical Performance After Treatment of Renal Anemia with Recombinant Human Erythropoietin. Nephron 1991; 58: 129–134
- Singh N.P., Chandrashekhar Nair M., Anuradha S., Kohli R., Agarwal S.K. The Cardiovascular and Hemodynamic Effects of Erythropoietin in Chronic Renal Failure. J. Assoc. Phys. India 2000; 48(3)301–306
- Macdougall I.C., Lewis N.P., Saunders M.J. Long-Term Cardio-Respiratory Effects of Amelioration of Renal Anemia by Erythropoietin. Lancet 1990; 335: 489–493
- Sunder-Plassman, Horl W.H. Importance of Iron Supply for Erythropoietin Therapy. Nephrol. Dial. Transplant. 1995; 10: 2070–2076
- Silverberg D.S., Blum M., Peer G. Intra Venous Ferric Saccharate as an Iron Supplement in Dialysis Patients. Nephron 1996; 72: 413–417
- Taylor J.E., Peat N., Porter C., Morgan A.G. Regular Low-Dose Intravenous Iron Therapy Improves Response Erythropoietin in Hemodialysis Patients. Nephron. Dial. Transplant. 1996; 11: 1079–1083
- Senger J.M., Weis R.J. Hematologic and Erythropoietin Responses to Iron Dextran in the Hemodialysis Environment. Am. Nephrol. Nurses Assoc. J. 1996; 23: 319–322
- Van Wyck D.B. Iron Management During Recombinant Human Erythropoietin Therapy. Am. J. Kidney Dis. 1989; 14: 9–13
- Markowitz G.S., Kahn G.A., Feingold R.E., Coco M., Lynn R.I. An Evaluation of the Effectiveness of Oral Iron Therapy in Hemodialysis Patients Receiving Recombinant Human Erythropoietin. Clin. Nephrol. 1997; 48: 34–40
- Kooistra M.P., Van Es A., Struy venberg A., Marx J.J.M. Low Iron Absorption in Erythropoietin-Treated Hemodialysis Patients. J. Am. Soc. Nephrol. 1995; 6: 543
- Goch J., Biregegard G., Danielson B.G., Wilstrom B. Iron Absorption in Patients with Chronic Uremia on Maintenance Hemodialysis and in Healthy Volunteers Measured with a Simple Oral Iron Load Test. Nephron 1996; 73: 403–406
- Eschbach J., De Oreo P., Adanson J. NKF-DOQI Clinical Practice Guidelines for the Treatment of Anemia of Chronic Renal Failure. Am. J. Kidney Dis. 1997; 30(suppl 3)S192–S240
- Wingad R.L., Parker R.A., Ismail N., Hakim R.M. Efficacy of Oral Iron Therapy in Patients Receiving Recombinant Human Erythropoietin. Am. J. Kidney Dis. 1995; 25: 433–439
- Nutrition and Health. Textbook of Preventive and Social Medicine, 16th Ed., K. Park, 2000; 405–451, chapter 10
- Dahdah K., Patrie J.T., Bolton W.K. Intravenous Iron Dextran Treatment in Predialysis Patients with Chronic Renal Failure. Am. J. Kidney Dis. 2000; 36(4)775–782
- Bhowmik D., Modi G., Ray D. Total Dose Iron Infusion: Safety and Efficacy in Predialysis Patients. Renal Failure 2000; 22(1)39–43